Dehydrozingerone protects temozolomide-induced cognitive impairment in normal and C6 glioma rats besides enhancing its anticancer potential

Considering the cognitive impairment induced by temozolomide (TMZ) in glioblastoma survivors, the present study was aimed to evaluate the protective effect of dehydrozingerone (DHZ) against TMZ-induced cognitive impairment (chemobrain) and C6 cell line-induced glioma in male Wistar rats. In both che...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:3 Biotech
Hauptverfasser: Pathak, Nandini, Cheruku, Sri Pragnya, Rao, Vanishree, Vibhavari, R. J. A., Sumalatha, Suhani, Gourishetti, Karthik, Rao, C. Mallikarjuna, Kumar, Nitesh
Format: Artigo
Sprache:Inglês
Veröffentlicht: Springer International Publishing 2020
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7498526/
https://ncbi.nlm.nih.gov/pubmed/32995109
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s13205-020-02427-7
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge